Successful treatment of nondelusional body dysmorphic disorder with olanzapine: A case report [4]

Journal of Clinical Psychiatry

Volumn 62, Issue 4, 2001, Pages 297-298

  Grant, J E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; OLANZAPINE; SEROTONIN;

ADULT; BODY DYSMORPHIC DISORDER; CASE REPORT; DRUG EFFECT; FEMALE; HUMAN; LETTER; OBSESSION; PHENOMENOLOGY; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0035022948     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n0413e     Document Type: Letter

References (13)

1. Body dysmorphic disorder: Diagnostic controversies and treatment challenges
2. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: Selective efficacy of a serotonin reuptake inhibitor in imagined ugliness
3. Body dysmorphic disorder: Does it have a psychotic subtype?
4. A comparison study of body dysmorphic disorder and obsessive-compulsive disorder
5. Monosymptomatic hypochondriacal psychosis: A diagnostic checklist based on 50 cases of the disorder
6. Body dysmorphic disorder: An obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both?
7. Body dysmorphic disorder: The distress of imagined ugliness
8. Olanzapine versus placebo in the treatment of acute mania
9. The study of olanzapine plus fluoxetine in treatment-resistant major depressive disorder without psychotic features
10. Obsessive compulsive spectrum disorder
11. Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder
12. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: An open-label case series
13. Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder